Anthony Cordone
@Armistice Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$6.253BTotal holdings256
Assets growth rate-21.32%Assets growth rate (2-Q avg)-7.96%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Armistice Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 256 positions.
Assets under management
The assets under management (AUM) of Armistice Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.253B in assets, with a quarterly growth rate of -21.32% and a 2-quarter average growth rate of -7.96%. The portfolio is managed by Anthony Cordone, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
FWRGFirst Watch Restaurant Group
| 0% | $3.249M 185,000 shares@ $17.56 avg price | Exited |
IPWIpower Inc
| 0% | $3.043M 1.463M shares@ $2.08 avg price | Exited |
TXG10x Genomics Inc
| 0% | $3.005M 154,482 shares@ $19.46 avg price | Exited |
LEXXLexaria Bioscience Corp
| 0% | $2.836M 1.02M shares@ $2.78 avg price | Exited |
CLSDClearside Biomedical Inc
| 0% | $2.777M 2.136M shares@ $1.3 avg price | Exited |
ALGSAligos Therapeutics Inc
| 0% | $2.54M 7.256M shares@ $0.36 avg price | Exited |
SLGLSol Gel Technologies
| 0% | $1.808M 2.032M shares@ $0.89 avg price | Exited |
IOBTIo Biotech Inc
| 0% | $1.808M 1.545M shares@ $1.17 avg price | Exited |
NRSNNeurosense Therapeutics Ltd
| 0% | $1.774M 1.584M shares@ $1.12 avg price | Exited |
GNLXGenelux Corporation
| 0% | $1.755M 900,000 shares@ $1.95 avg price | Exited |